Mesoporous silica nanoparticles for drug and gene delivery

Yixian Zhou(Sun Yat-sen University), Chuanbin Wu(Laboratoire de Chémo-biologie synthétique et thérapeutique), Boyi Niu(Sun Yat-sen University), Biyuan Wu(Sun Yat-sen University), Xin Pan(Henan Normal University), Xiaoxu Zhang(Qingdao Huanghai University), Guilan Quan(Laboratoire de Chémo-biologie synthétique et thérapeutique), Qiaoli Wu, Ying Huang(Tianjin University of Traditional Chinese Medicine)
Acta Pharmaceutica Sinica B
February 12, 2018
10.1016/j.apsb.2018.01.007
Cited by 691

Related Papers

Application of glutathione depletion in cancer therapy: Enhanced ROS-based therapy, ferroptosis, and chemotherapy
|Biomaterials|2021|1.1k
Microneedle-mediated transdermal drug delivery for treating diverse skin diseases
|Acta Biomaterialia|2020|247
Membrane-disruptive peptides/peptidomimetics-based therapeutics: Promising systems to combat bacteria and cancer in the drug-resistant era
|Acta Pharmaceutica Sinica B|2021|176
Strategy for hypertrophic scar therapy: Improved delivery of triamcinolone acetonide using mechanically robust tip-concentrated dissolving microneedle array
|Journal of Controlled Release|2019|153
<i>In Situ</i> Self-Assembly Nanomicelle Microneedles for Enhanced Photoimmunotherapy <i>via</i> Autophagy Regulation Strategy
|ACS Nano|2021|139